Replies to post #227666 on Biotech Values

[DewDiligence]

AMRN/MDCO/NVS—Which drug has a larger NPV as of today: Vascepa or Inclisiran?

(I could make this a poll question, but there are so many AMRN fans in these parts that the outcome of the poll may be a foregone conclusion.)